In vitro studies revealed that recombinant human TGM2 causes a sustained increase in the enzyme activity of recombinant human sPLA2-X identifying a previously unknown mechanism of asthma in which the increase in TGM2 in the airways may function to amplify airway inflammation through eicosanoid generation. This evidence concerns the gene PLA2G10 and asthma.